Abstract
Obesity and pain are common problems affecting the older adult and a possible relationship between the two is considered. Obesity and pain themselves are significant burdens on the individual, the healthcare system, and society as a whole and they can lead to emotional conditions such as stress, anxiety, and depression – which lead to further healthcare utilization and burden. Cross-sectional studies have revealed a high correlation between pain and obesity and a few longitudinal studies implicate obesity as a risk factor for the development of pain and the associated reduction in quality of life. Obesity leads to pain due to mechanical stress and metabolic disruptions, so mitigating obesity may help reduce the risk of developing pain and improve recovery from pain. More research is warranted to elucidate the mechanistic links between obesity and pain and to determine the optimal treatment strategies for reducing these comorbities. Reducing obesity could reduce pain medication burden.
Keywords: Chronic pain, obesity, quality of life, osteoarthritis, fibromyalgia, inflammation.
Current Pharmaceutical Design
Title:Pain and Obesity in the Older Adult
Volume: 20 Issue: 38
Author(s): Robert Taylor Jr., Joseph V. Pergolizzi Jr., Robert B. Raffa, Srinivas Nalamachu and Philip J. Balestrieri
Affiliation:
Keywords: Chronic pain, obesity, quality of life, osteoarthritis, fibromyalgia, inflammation.
Abstract: Obesity and pain are common problems affecting the older adult and a possible relationship between the two is considered. Obesity and pain themselves are significant burdens on the individual, the healthcare system, and society as a whole and they can lead to emotional conditions such as stress, anxiety, and depression – which lead to further healthcare utilization and burden. Cross-sectional studies have revealed a high correlation between pain and obesity and a few longitudinal studies implicate obesity as a risk factor for the development of pain and the associated reduction in quality of life. Obesity leads to pain due to mechanical stress and metabolic disruptions, so mitigating obesity may help reduce the risk of developing pain and improve recovery from pain. More research is warranted to elucidate the mechanistic links between obesity and pain and to determine the optimal treatment strategies for reducing these comorbities. Reducing obesity could reduce pain medication burden.
Export Options
About this article
Cite this article as:
Jr. Taylor Robert, Jr. V. Pergolizzi Joseph, Raffa B. Robert, Nalamachu Srinivas and Balestrieri J. Philip, Pain and Obesity in the Older Adult, Current Pharmaceutical Design 2014; 20 (38) . https://dx.doi.org/10.2174/1381612820666140316131431
DOI https://dx.doi.org/10.2174/1381612820666140316131431 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic: Cardiac Cell Therapy: anno 2011 (Executive Guest Editor: Sophie Van Linthout)
Current Pharmaceutical Design Advances in Irrigated Tip Catheter Technology for Treatment of Cardiac Arrhythmias
Recent Patents on Cardiovascular Drug Discovery Herbal Medicine for Slowing Aging and Aging-associated Conditions: Efficacy, Mechanisms and Safety
Current Vascular Pharmacology From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes
Current Pharmaceutical Design Serotonin and Obesity
Current Medicinal Chemistry - Central Nervous System Agents The Pathophysiological Basis of Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
Current Vascular Pharmacology Post-traumatic Stress Disorder in Heart Failure Patients: A Test of the Cardiac Disease-induced PTSD Hypothesis
Current Psychiatry Research and Reviews Monoamine Receptors in the Regulation of Feeding Behaviour and Energy Balance
CNS & Neurological Disorders - Drug Targets Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research Myricetin Induces Apoptosis in HepG2 Cells Through Akt/p70S6K/Bad Signaling and Mitochondrial Apoptotic Pathway
Anti-Cancer Agents in Medicinal Chemistry Linezolid - The First Oxazolidinone in the Treatment of Nosocomial MRSA Pneumonia
Recent Patents on Anti-Infective Drug Discovery Oral Infection and Vascular Disease
Vascular Disease Prevention (Discontinued) Metabolic Syndrome During Menopause
Current Vascular Pharmacology Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Controversies of Dopamine Agonists: Somnolence, Cardiac Valvulopathy and Repetitive Behaviors
Current Drug Therapy The Role of the Stress-Related Anti-Inflammatory Hormones ACTH and Cortisol in Atherosclerosis
Current Vascular Pharmacology Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Current Pharmaceutical Design Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis
Current Vascular Pharmacology Macrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque Rupture
Current Vascular Pharmacology A Glance Over the Cannabinoid Machinery to Design New Anti- Angiogenic Compounds
Mini-Reviews in Medicinal Chemistry